ALC - Alcon AG - Stock Price & Dividends
Exchange: SIX Swiss Exchange • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0432492467
Contact Lenses, Intraocular Lenses, Surgical Equipment
Alcon AG is a leading eye care company that designs, manufactures, and distributes a wide range of products and solutions for eye care professionals and their patients globally. The company operates through two main segments: Surgical and Vision Care.
The Surgical segment offers a comprehensive portfolio of products and equipment for surgical procedures, including cataract removal and refractive surgery. This includes advanced technologies such as the Centurion vision system, LenSx laser system, and NGENUITY 3D visualization system, which enable surgeons to perform complex procedures with precision and accuracy. The segment also provides consumables such as viscoelastics, surgical solutions, and incisional instruments, as well as implantable products like AcrySof IQ intraocular lenses (IOLs) that correct presbyopia and astigmatism during cataract surgery.
In addition to cataract products, the Surgical segment also offers vitreoretinal products, including constellation vision systems, procedure packs, lasers, and hand-held microsurgical instruments. These products are designed to help surgeons treat complex retinal diseases and conditions. The segment also provides refractive surgery products, such as WaveLight lasers, which are used for LASIK treatment, as well as implantable products like the EX-PRESS glaucoma filtration device.
The Vision Care segment focuses on providing a range of products for everyday eye care, including daily disposable, reusable, and color-enhancing contact lenses. The segment also offers ocular health products, such as dry eye treatments, glaucoma medications, contact lens care solutions, and ocular allergy relief products. Furthermore, the segment provides ocular vitamins and redness relievers to promote overall eye health and comfort.
With a rich history dating back to 1945, Alcon AG is headquartered in Geneva, Switzerland, and has evolved over the years to become a global leader in the eye care industry. Today, the company continues to innovate and expand its product portfolio to meet the evolving needs of eye care professionals and their patients worldwide.
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for ALC - Alcon AG - Stock Price & Dividends](https://www.valueray.com/images/drawdown_chart/ALC.SW_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for ALC - Alcon AG - Stock Price & Dividends](https://www.valueray.com/images/chart/ALC.SW_seasonality.png)
ALC Stock Overview
Market Cap in USD | 45,031m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception |
ALC Stock Ratings
Growth 5y | 37.4 |
Fundamental | 44.9 |
Dividend | 41.1 |
Rel. Performance vs Sector | 1.28 |
Analysts | - |
Fair Price Momentum | 77.86 CHF |
Fair Price DCF | 50.51 CHF |
ALC Dividends
Dividend Yield 12m | 0.29% |
Yield on Cost 5y | 0.41% |
Dividends CAGR 5y | 2.53% |
Payout Consistency | 90.0% |
ALC Growth Ratios
Growth 12m | 12.16% |
Growth Correlation 12m | 40% |
Growth Correlation 3m | 24% |
CAGR 5y | 7.09% |
CAGR/Mean DD 5y | 0.65 |
Sharpe Ratio 12m | 0.33 |
Alpha vs SP500 12m | -8.37 |
Beta vs SP500 5y weekly | 0.98 |
ValueRay RSI | 85.30 |
Volatility GJR Garch 1y | 18.16% |
Price / SMA 50 | 2.94% |
Price / SMA 200 | 15.28% |
Current Volume | 646k |
Average Volume 20d | 588.6k |
External Links for ALC Stock
As of July 27, 2024, the stock is trading at CHF 83.00 with a total of 645,988 shares traded.
Over the past week, the price has changed by +3.80%, over one month by +3.57%, over three months by +15.28% and over the past year by +12.10%.
According to ValueRays Forecast Model, ALC Alcon AG will be worth about 86 in July 2025. The stock is currently trading at 83.00. This means that the stock has a potential upside of +3.64%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 84.8 | 2.12 |
Analysts Target Price | - | - |
ValueRay Target Price | 86 | 3.64 |